South African researchers hope to restart J&J vaccination next week

South African researchers hope to restart use of Johnson & Johnson's COVID-19 vaccine next week in an "implementation study" immunising healthcare workers, a top local scientist said on Wednesday. South Africa suspended the study last week after U.S. federal health agencies recommended pausing use of J&J's vaccine because of rare cases of blood clots.

"We do hope to start again next week," South African Medical Research Council President Glenda Gray said during a webinar.